SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-15-002426
Filing Date
2015-05-15
Accepted
2015-05-15 07:50:02
Documents
9
Period of Report
2015-05-13

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tnib_10q.htm 10-Q 697097
2 CERTIFICATION tnib_ex311.htm EX-31.1 17160
3 CERTIFICATION tnib_ex321.htm EX-32.1 16361
  Complete submission text file 0001354488-15-002426.txt   3163057

Data Files

Seq Description Document Type Size
4 tnib-20150331.xml EX-101.INS 353918
5 tnib-20150331.xsd EX-101.SCH 41730
6 tnib-20150331_cal.xml EX-101.CAL 34229
7 tnib-20150331_def.xml EX-101.DEF 42921
8 tnib-20150331_lab.xml EX-101.LAB 212007
9 tnib-20150331_pre.xml EX-101.PRE 135661
Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54933 | Film No.: 15865506
SIC: 2834 Pharmaceutical Preparations